Open AccessDaratumumab Granted Breakthrough Therapy Designation for Double-Refractory Multiple Myeloma
Publication year - 2013
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000430986.30927.3f
Subject(s) - daratumumab , multiple myeloma , refractory (planetary science) , medicine , oncology , lenalidomide , biology , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom